Pursuant to Article L. 5122-6 of the Public Health Code, the High Council for Public Health has determined the minimum information required to advertise the Priorix® vaccine against measles-mumps-rubella. Statement issued by the French Commission of experts on communicable diseases (Commission spécialisée maladies transmissibles), on the proposal of the Technical Vaccination Committee (Comité technique des vaccinations - CTV) on May 28, 2010. Source : http://www.hcsp.fr/docspdf/avisrapports/hcspa20100528_mmo_Priorix.pdf

Europe France health policy Measles Mumps Rubella